Measles / Mumps / Rubella /Varicella Vaccine
Vaccine / immunological product
What it is used for
Measles, mumps, rubella, and varicella immunization Clinical selection for Measles / Mumps / Rubella /Varicella Vaccine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Vaccine / immunological product. Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Suspend immunizations after infection, high dose of systemic corticosteroids, blood transfusion for at least 3 months, carcinogenic or radiation therapy. Avoid I.V injection. Avoid use in allergic patients, history of convulsions.
Possible side effects
[Measles] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels. [Mumps] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.